Organisational structure chart - North Bristol NHS Trust

For more information and advice visit: www.nhs.uk or www.111.nhs.uk If you or a member of your household has symptoms of coronavirus, please call your midwife or maternity team before

BLOOD SCIENCES DEPARTMENT OF CLINICAL BIOCHEMISTRY Title of Document: Hyperlipidaemia Treatment Guidelines Q Pulse Reference No: CB/DCB/PROTOCOLS/27 Version NO: 4 Authoriser: Peter

Information required Patient name, sex and age Dosage and frequency and timing of samples Clinical summary Other medications important Address for report Phone fax if preferred

Trust Board Chief Executive Maria Kane Chair Michele Romaine Director of Corporate Governance & Trust Secretary Xavier Bell Tim Gregory Kelly Macfarlane Kelvin Blake John

Figure 1 : Inputs to this plan NBT 2-year Operational Plan NBT Financial Recovery Plan NBT Directorate Plans BNSSG STP NBT Quality Improvement Programme NHSI Agency

Trust Board Chief Executive Maria Kane Chair Michele Romaine Director of Corporate Governance & Trust Secretary Xavier Bell Tim Gregory Kelly Macfarlane Kelvin Blake John

3668 End date 01/02/2021 BASIL-3 Multi-centre randomised controlled trial of clinical and cost- effectiveness of drug coated balloons, drug eluting stents and plain balloon angioplasty

R&I No Project Title Project Description 3668 End date: 15/02/2021 BASIL-3 Multi-centre randomised controlled trial of clinical and cost- effectiveness of drug coated balloons,